MANKINDstockMankind Pharma Ltd
₹2,361.95
▲+0.22%
Open
₹2,345.15
High
₹2,380
Low
₹2,345.15
Volume
203.2K
Price chart
Daily close · downsampled 5-year history
2023-05-09 · ₹1,424.052026-06-18 · ₹2,397.9
Instrument details
- MB Code
- MBEQU1587
- Type
- stock
- ISIN
- INE634S01028
- BSE
- 543904
- Industry
- Pharmaceuticals & Biotechnology
Latest earnings
Q4FY26 declared
- Quarter
- Mar 2026
- Revenue
- 3442.93 Cr
- Net profit
- 559.42 Cr
- EPS
- 13.41
- YoY revenue
- +11.81%
Price returns
Historical performance
- 1 day
- +1.46%
- 1 month
- -3.86%
- 3 months
- +19.91%
- 1 year
- +1.86%
- 3 years
- +40.68%
- 5 years
- +68.39%
Technicals
Indicator consensus
Bullish
32
Neutral
7
Bearish
7
RSI 63.93(Neutral)
Company documents
Annual reports, concalls, presentations
Concall transcripts
28Investor presentations
36Corporate announcements
316Corporate timeline
Price chart events · 1 year
Dividend
2025-08-08
{"amount":1}
Earnings
2026-02-03
{"actualRevenue":35672000000,"estimateRevenue":36570000000,"revenueSurprise":-898000000,"revenueSurprisePercent":-2.455564670494941,"actualEPS":12.47,"estimateEPS":12.393,"surprise":0.07699999999999996,"surprisePercent":0.6213184862422332}
Earnings
2026-05-19
{"actualRevenue":34429300000,"estimateRevenue":34492000000,"revenueSurprise":-62700000,"revenueSurprisePercent":-0.1817812826162588,"actualEPS":13.97,"estimateEPS":10.8528,"surprise":3.1172,"surprisePercent":28.72254164823825}
Earnings
2025-11-06
{"actualRevenue":36971600000,"estimateRevenue":36922000000,"revenueSurprise":49600000,"revenueSurprisePercent":0.1343372515031688,"actualEPS":12.38,"estimateEPS":13.974,"surprise":-1.593999999999999,"surprisePercent":-11.40689852583369}
News
2026-05-19
{"description":"Mankind Pharma’s Q4FY26 profit rose 30.4% on stronger domestic demand, led by chronic therapies and OTC healthcare products, signaling solid earnings momentum.","url":"https://www.business-standard.com/companies/quarterly-results/mankind-pharma-q4-pat-rises-30-on-strong-domestic-biz-chronic-push-126052000005_1.html","sentiment":"Positive","domain":"Business Standard"}
News
2026-05-19
{"description":"Mankind Pharma reported Q4 revenue up 11.8% to ₹3,443 crore, EBITDA up 36.1% and margin at 27%; India sales grew 13% on chronic therapy strength, while net profit was nearly flat.","url":"https://www.cnbctv18.com/market/mankind-pharma-q4-results-revenue-rises-12-pc-chronic-therapies-drive-margin-expansion-ws-el-19909312.htm","sentiment":"Positive","domain":"CNBCTV18"}
News
2025-07-11
{"description":"Mankind Pharma shares rose 4.93% to Rs 2,669.50, showing strong momentum today with increased trading volume, making it one of the top gainers on Nifty Midcap 150.","url":"https://www.moneycontrol.com/news/business/stocks/mankind-pharma-shares-jump-4-93-amid-volume-surge-stock-among-top-gainers-on-nifty-midcap-150-alpha-article-13265879.html","sentiment":"Positive","domain":"Moneycontrol"}
News
2025-07-05
{"description":"Stay updated with the latest news and announcements from Mankind Pharma, including stock quotes and market insights from The Economic Times.","url":"https://economictimes.indiatimes.com/mankind-pharma-ltd/stocksupdate/companyid-38548.cms","sentiment":"Neutral","domain":"Indiatimes"}